Showing results 1 to 5 of 5
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2022 | 15 | |||
Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 Journal:Nature Communications | 2021 | 1 | ||
Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants Journal:Emerging Microbes & Infections | 2022 | 2 | ||
Peptidic defective interfering gene nanoparticles against Omicron, Delta SARS-CoV-2 variants and influenza A virus in vivo Journal:Signal Transduction and Targeted Therapy | 2022 | 2 | ||
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells Journal:Emerging Microbes & Infections | 2022 | 11 |